Previous Article | Next Article ![]()
Journal of Clinical Microbiology, January 2000, p. 453-455, Vol. 38, No. 1
Medical Microbiology Division, Department of
Pathology, University of Iowa College of Medicine, Iowa City, Iowa
Received 26 May 1999/Returned for modification 6 October
1999/Accepted 28 October 1999
This multicenter study proposes antimicrobial susceptibility (MIC
and disk diffusion methods) quality control (QC) parameters for seven
compounds utilized in veterinary health. Alexomycin, apramycin,
tiamulin, tilmicosin, and tylosin were tested by broth microdilution
against various National Committee for Clinical Laboratory Standards
(NCCLS)-recommended QC organisms (Staphylococcus aureus
ATCC 29213, Enterococcus faecalis ATCC 29212, Streptococcus pneumoniae ATCC 49619, Escherichia
coli ATCC 25922, and Pseudomonas aeruginosa ATCC
27853). In addition, disk diffusion zone diameter QC limits were
determined for apramycin, enrofloxacin, and premafloxacin by using
E. coli ATCC 25922, P. aeruginosa ATCC 27853, and S. aureus ATCC 25923. The results from five or six
participating laboratories produced
0095-1137/0/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Quality Control Guidelines for Disk Diffusion and
Broth Microdilution Antimicrobial Susceptibility Tests with Seven
Drugs for Veterinary Applications
99.0% of MICs and
95.0% of
the zone diameters within suggested guidelines. The NCCLS Subcommittee
for Veterinary Antimicrobial Susceptibility Testing has recently
approved these ranges for publication in the next M31 document.
*
Corresponding author. Mailing address: Medical
Microbiology Division, 251 MRC, Department of Pathology, University of
Iowa College of Medicine, Iowa City, IA 52242. Phone: (319) 335-8168. Fax: (319) 335-8141. E-mail: ronald-jones{at}uiowa.edu.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»